Non-small cell lung cancer

• Safety, immunogenicity and preliminary clinical activity study of PDC*lung01 cancer vaccine in NSCLC Ended
  2024-517429-24-00 7 2020-01-09 "Non-small-cell lung cancer"
• REGN5093 in Patients With MET-Altered Advanced Non-Small Cell Lung Cancer Ended
  2023-506248-18-00 7 2020-01-07 "MET-altered non-small cell lung cancer (NSCLC)"
• Neoadjuvant nivolumab combination treatment in resectable non-small cell lung cancer patients: Defining optimal combinations and determinant … Ended
  2024-513074-22-00 4 2019-12-02 "non-small cell lung cancer (NSCLC) of clinical stages IB, II"
• Precision Immuno-Oncology for advanced Non-small cell lung cancer patients with PD-1 ICI Resistance (PIONeeR clinical study) Ended
  2024-515532-72-00 4 2019-10-08 "non small cell lung cancer"
• A study comparing combination of Encorafenib + Binimetinib in Patients with BRAF V600-mutant Non-small Cell Lung Cancer. Ended
  2024-515929-28-00 4 2019-08-02 "Non-small Cell Lung Cancer"
• A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specifi … Ended
  2024-511798-31-00 7 2019-05-31 "KRAS p.G12C Mutant Advanced Solid Tumors"
• Study of efficacy and safety of pembrolizumab plus platinum-based doublet chemotherapy with or without canakinumab in previously untreated l … Ended
  2024-511490-29-00 5 2019-01-24
• Study of subcutaneous nivolumab monotherapy with or without Recombinant Human Hyaluronidase PH20 (rHuPH20) Ended
  2023-503554-12-00 9 2019-01-09 "lung cancer; kidney cancer; melanoma; liver cancer; colorect"
• A clinical study to investigate if the investigational products, called LN-144 and LN-145 (also known as Tumour Infiltrating Lymphocytes), a … Ended
  2024-510779-39-00 4 2018-12-19 "Neoplasm"
• First line treatment with osimertinib in non-small cell lung cancer, coupled with studies on biological samples. Ended
  2024-513881-20-00 4 2018-11-19 "EGFR-mutated non-small cell lung cancer"
• A Phase II trial find out the effectiveness and safety of durvalumab combined with olaparib compared to durvalumab alone, in treating patien … Ended
  2024-512769-16-00 4 2018-11-14 "Stage IV Non Small Cell Lung Cancer whose tumors lack EGFR m"
• Combinations of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in Patients With Lung Cancer Ended
  2024-515051-38-00 5 2018-07-20 "Non-small Cell Lung Cancer"
• A Study to Assess Tiragolumab in Combination With Atezolizumab in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Non-Small … Ended
  2023-508083-30-00 4 2018-07-19 "Non-small cell lung cancer (NSCLC)"
• Study of durvalumab/placebo + chemoradiation therapy in Patients with Unresectable, Locally Advanced Non-small Cell Lung Cancer Ended
  2024-515321-29-00 5 2018-06-26 "Patients with Locally Advanced, Unresectable Non-small Cell "
• A Study Evaluating the Efficacy and Safety of Neoadjuvant Treatment with Atezolizumab or Placebo in Combination with Platinum-Based Chemothe … Ended
  2023-504209-35-00 5 2018-04-04 "Early-Stage Resectable Non-small cell lung cancer (NSCLC)"
• Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) Ended
  2024-515052-20-00 5 2017-09-20 "Non-small Cell Lung Cancer"
• A Neoadjuvant Study of Nivolumab plus Ipilimumab or Nivolumab plus Chemotherapy versus Chemotherapy alone in Early Stage Non-Small Cell Lung … Ended
  2022-501360-18-00 5 2017-03-15 "Early Stage Non-Small Cell Lung Cancer (NSCLC)"
• A clinical trial to evaluate if CC-486 plus pembrolizumab works and is safe in patients with advanced or metastatic non-small cell lung canc … Ended
  2024-513405-31-00 4 2015-12-10 "Second-line treatment of locally advanced or metastatic non-"
• A randomized, phase 3 trial with anti-PD-1 monoclonal antibody pembrolizumab (MK-3475) versus placebo for patients with early stage NSCLC af … Ended
  2023-509137-39-00 5 2015-11-06 "Stage IB (T ≥ 4 cm), II and IIIA NSCLC"
• Safety Study of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors Ended
  2023-508067-70-00 9 2015-04-15 "Neoplasms by site"
• A Phase 1/2 Study of DCC-3116 in Patients With MAPK Pathway Mutant Solid Tumors Ended
  2022-501474-19-00 7 "Non-Small Cell Lung Cancer"
• C6081001: A Phase 1 Study of PF-07985045 in Participants with Advanced Solid Tumors Ended
  2024-517988-23-00 1 "KRAS mutated advanced solid tumors"
• SPECT/CT imaging of FPI-2505 in patients with solid tumours; a phase 0 molecular imaging basket trial (SCOPE-study). Ended
  2025-521235-37-00 1 "small cell lung cancer, non-smallcell lung cancer, colorecta"

Showing 217–239 of 239 trials